CD19 and chronic kidney disease: Among splenic B‐cells there were more follicular B2 (CD23+) and less marginal zone (CD23−/IgM+) cells as a percentage of total B2 cells (CD19+/B220+) in CKD conditions compared with control (Figure S9A).